Last week in separate deals with the GAVI Alliance, the drug companies Pfizer and GlaxoSmithKline (GSK) agreed to increase sales of cut-price pneumonia vaccines by 180 million doses, a 50% increase from previous commitments.

Dr. Ciro de Quadros appointed to Decade of Vaccines (DoV) Collaboration leadership

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.

Gift giving can become tiresome. There is the shopping, and the wondering if your online shipment will arrive in time, or worse, actually going to a mall. There is the wrapping, but remember, not before you fly. Then, of course, there is the deflated feeling that it really doesn’t matter.

Participants gather for a “family photo” at Sabin’s First Vaccinology Course for Latin America, Lima, Peru, 12-16 December 2011.

Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

2012 Albert B. Sabin Gold Medal Award Call for Nominations

November 30, 2011

The Sabin Vaccine Institute is honored to invite you to nominate a distinguished colleague for the 2012 Albert B. Sabin Gold Medal Award.

How to Nominate Your Distinguished Colleague

In order to nominate your colleague for the Gold Medal Award, provide a one-page explanation of the nominee’s most important vaccine research or advocacy contributions and why you believe they are particularly important. Please submit your nomination no later than Friday, December 16, 2011 to the following address:

Sabin

This is the fifth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

This is the fourth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Late last week, the GAVI Alliance board announced its plan to fund the introduction of vaccine

Pages

Subscribe to RSS - Vaccine Advocacy and Education